Read More Pharma Industry News Rubicon Research IPO: Can General Atlantic’s Rs 1,377cr exit test pharma market appetite? Rubicon Research’s ₹1,377 crore IPO opens Oct 9. Backed by General Atlantic, can this pharma play sustain growth and deliver listing gains? byPallavi MadhirajuOctober 3, 2025